CCN4 and colitis: WISP1 expression was also found to be increased in 2,4,6-trinitrobenzenesulfonic acid- (TNBS-) induced experimental mouse colitis, a model similar to human Crohn's disease [19–21], and treatment with rWISP1 significantly exacerbated TNBS-induced colitis.